Blood and tissue sampling: Tissue samples (tumor tissue and healthy tissue) frozen and secured in paraffin collected during surgery.
During the blood samples taken for diagnosis and / or treatment when possible. Additional samples for research purposes will be carried out, these blood samples will be collected:
* before any therapeutic intervention (T1) for a total volume of 36mL,
* prior to surgery (T-Surg) for a total volume of 24mL,
* at each progression (T2a, b, c…) for a total volume of 24mL,
* at the end of follow-up (T3) for a total volume of 24mL.
Study summary
A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical data to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to bronchial cancer.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Male or female patient aged over 18 years,
* Histologically or cytologically confirmed bronchial cancer,
* Treatment-naïve patient for the current cancer,
* Patient who has provided informed, written, and explicit consent,
* Patient affiliated with the French national health insurance system.
Exclusion Criteria:
* Patient with a WHO performance status ≥ 3,
* Pregnant and/or breastfeeding woman,
* Patient with a history of other cancers within the 5 years preceding inclusion,
* Patient for whom regular follow-up is considered impossible due to psychological, familial, social, or geographic reasons,
* Patient under legal protection (guardianship, curatorship, or judicial protection).
Primary outcome measure(s)
Proportion of patients who consent to participate in the study — through study completion : an average of 1 year the proportion of patients who consent to participate in the study among the screened patients
Trial sites (1)
Facility
City
Region
Status
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Montpellier
France
More Institut du Cancer de Montpellier - Val d'Aurelle trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
